Homeostatic Control of GLP-1 and Protein Localization: A Comprehensive Review
Introduction
Glucagon-like peptide-1 (GLP-1) is a key regulator of glucose homeostasis and food intake regulation, playing a crucial role in various physiological processes. Recent studies have shed new light on the mechanisms underlying GLP-1-induced appetite and bodyweight regulation, and the proliferation of modern neuroscience and genetic approaches has further refined our understanding of GLP-1's role in homeostatic control. This review aims to provide an in-depth analysis of the current knowledge on GLP-1 and protein localization, with a focus on its homeostatic control mechanisms.GLP-1 and Homeostatic Control
GLP-1 is a class B Gprotein-coupled receptor (GPCR) that is activated directly or indirectly by blood glucose-lowering agents, such as GLP-1 receptor agonists (GLP-1RAs). These agents have shown promise in improving glycemic control and reducing weight in individuals with type 2 diabetes mellitus (T2DM). GLP-1's role in homeostatic control is multifaceted, involving the regulation of glucose homeostasis, insulin secretion, and satiety.Protein Localization and Homeostatic Control
Recent studies have highlighted the importance of protein localization in regulating GLP-1's homeostatic control mechanisms. The GLP-1 receptor (GLP-1R) is subject to redistribution within nanoregions of the plasma membrane and throughout the endocytic network, enabling complex patterns of signaling at different locations. This redistribution is crucial for GLP-1's ability to regulate glucose homeostasis and energy balance.Subcellular Localization of GLP-1R
